Kiromic BioPharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KRBP and buy or sell other stocks, ETFs, and their options commission-free!About KRBP
Kiromic Biopharma, Inc. is a clinical stage biotherapeutics company, which engages in DIAMOND AI and discovers, validates, and develops cell and gene therapies with a therapeutic focus on immuno-oncology. The firm is in the process of developing ALEXIS, a multi-indication allogeneic CAR-T cell therapy platform that exploits the natural potency of gamma delta T-cells to target solid cancers.
CEOPietro Bersani, CPA
CEOPietro Bersani, CPA
Employees—
Employees—
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2006
Founded2006
Employees—
Employees—
KRBP Key Statistics
Market cap200.00
Market cap200.00
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume37.11
Average volume37.11
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.005
52 Week high$0.005
52 Week low—
52 Week low—
Stock Snapshot
With a market cap of 200, Kiromic BioPharma(KRBP) trades at $0.00.
On 2026-09-08, Kiromic BioPharma(KRBP) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 37.11.
People also own
Based on the portfolios of people who own KRBP. This list is generated using Robinhood data, and it’s not a recommendation.